Skip to content

A trial to study the effect of Yoga in Ulcerative colitis patients.

To study the effectiveness of standard medical therapy with yoga compared to standard medical therapy for the treatment of mild to moderate ulcerative colitis. A randomized control study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103854
Enrollment
100
Registered
2026-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

Intervention1: Yoga + Standard therapy: In addition to standard of care conventional IBD treatment, intervention participants will receive Yoga. The 12 week Hatha Yoga intervention include 2 component

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age more 18 years 2. Diagnosed cases of UC by endoscopy and biopsy. 3. Patients with mild to moderate disease.

Exclusion criteria

Exclusion criteria: 1. Patients in remission 2. Patients having toxic megacolon 3. Patients with Crohn s disease, microscopic colitis, and celiac disease 4. Patients with uncertain diagnosis 5. Patients with infectious colitis and exposure to radiation 6. Patient unwilling to participate in study 7. Lactating and pregnant females 8. Patients with suspected or proven malignancy of any organ and GI malignancy 9. Patients with severe co-morbidities 10. Previous history of venous thromboembolism. 11. Patients undergoing major surgery. 12. History of prolonged immobilisation. 13. Myocardial infarction (within previous 3 months)/Heart failure

Design outcomes

Primary

MeasureTime frame
The proportion of subjects in remission at the end of week 12.Timepoint: The proportion of subjects in remission at the end of week 12.

Secondary

MeasureTime frame
The proportion of subjects achieving mucosal healing at Week 12. Clinical response at 12weeks. change in inflammatory biomarkers.Timepoint: At 12weeks

Countries

India

Contacts

Public ContactGourav Sahu

PGIMER Chandigarh

sahu.gourav15@gmail.com8966030146

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026